Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Harris

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Palliative Medicine|April 23, 2016
Interdisciplinary Team Care and Hospice Team Provider Visit Patterns during the Last Week of LifeLee Ellington, Margaret F Clayton, Maija Reblin, et al.
Journal of the American Geriatrics Society|January 26, 2013
Patterns of functional decline in hospice: what can individuals and their families expect?Pamela Harris, Esther Wong, Sue Farrington, et al.
Journal of the National Cancer Institute|November 11, 2015
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer InstituteJoshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
Endocrine|July 8, 2017
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paragangliomaSina Jasim, Vera J Suman, Camilo Jimenez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignanciesShivaani Kummar, Larry Anderson, Kimberly Hill, et al.
Cancer|February 27, 2016
Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation ProgramAlexander Drilon, Anne A Eaton, Katja Schindler, et al.
Toxins|October 13, 2017
The Aspergillus flavus Homeobox Gene, hbx1, is Required for Development and Aflatoxin ProductionJeffrey W Cary, Pamela Harris-Coward, Leslie Scharfenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Palliative Medicine|April 23, 2016
Interdisciplinary Team Care and Hospice Team Provider Visit Patterns during the Last Week of LifeLee Ellington, Margaret F Clayton, Maija Reblin, et al.
Journal of the American Geriatrics Society|January 26, 2013
Patterns of functional decline in hospice: what can individuals and their families expect?Pamela Harris, Esther Wong, Sue Farrington, et al.
Journal of the National Cancer Institute|November 11, 2015
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer InstituteJoshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
Endocrine|July 8, 2017
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paragangliomaSina Jasim, Vera J Suman, Camilo Jimenez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignanciesShivaani Kummar, Larry Anderson, Kimberly Hill, et al.
Cancer|February 27, 2016
Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation ProgramAlexander Drilon, Anne A Eaton, Katja Schindler, et al.
Toxins|October 13, 2017
The Aspergillus flavus Homeobox Gene, hbx1, is Required for Development and Aflatoxin ProductionJeffrey W Cary, Pamela Harris-Coward, Leslie Scharfenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerKeith C Bible, Vera J Suman, Michael E Menefee, et al.
Pageof 3